GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Cash from Discontinued Operating Activities

Emcure Pharmaceuticals (NSE:EMCURE) Cash from Discontinued Operating Activities : ₹0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Emcure Pharmaceuticals's Cash from Discontinued Operating Activities for the three months ended in Mar. 2025 was ₹0 Mil. It means Emcure Pharmaceuticals received ₹0 Mil from discontinued investing activities. Emcure Pharmaceuticals's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0 Mil.

Emcure Pharmaceuticals Cash from Discontinued Operating Activities Historical Data

The historical data trend for Emcure Pharmaceuticals's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Cash from Discontinued Operating Activities Chart

Emcure Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Cash from Discontinued Operating Activities
- - - - -

Emcure Pharmaceuticals Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only - - - - -

Emcure Pharmaceuticals Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emcure Pharmaceuticals Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Cash from Discontinued Operating Activities
Comparable Companies
NSE:GLAND BOM:506943 BOM:532300 BOM:543635 BOM:540596 BOM:506820 BOM:533573 BOM:530019 BOM:540222 BOM:524742 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
544210:India
Address
Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057
Website
https://www.emcure.com
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines